Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Women above the age of 18 years with metastatic palpable axillary lymph nodes confined to level 1 with invasive breast cancer in the ipsilateral breast. 2.Locally advanced breast cancer patients who have received neoadjuvant chemotherapy.( T3N0,T3N1, )
Exclusion criteria
Exclusion criteria: 1.Women with inflammatory breast cancer, skin involvement and chest wall involvement as they should undergo complete axillary lymph node dissection. 2.Pregnant women 3.Lactating women 4.Women refusing to sign consent form. 5.Patients allergic to injection Benzathine penicillin 6.Patients with advanced disease including N3, and metastatic disease. 7.Upper limb swelling with deep vein thrombosis 8.Acute infections of upper limb. 9.Refusals for consent for randomization or long follow up. 10.Patients with established upper limb lymphedema. (Pre operative difference of >2cm in both upper limbs circumference)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Risk of lymphoedemaTimepoint: week 4 ,8, 12, 24 and week 52 | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical site infection. Quality of life score. Arm and shoulder Pain . Paraesthesia recorded on visual analogue scale (VAS) of 0 to 10. Seroma in axilla. Episodes of cellulitis and DLA in the operated upper limb. Timepoint: week 4 ,8, 12, 24 and week 52 | — |
Countries
India
Contacts
All India Institute of Medical Sciences